Here are relevant reports on : minimal-residual-disease-mrd-market
-
Foregut Surgery Devices Market by Product (Endoscope, Hand Instrument), Procedure (Complex Esophagogastric Surgery, Per-Oral Endoscopic Myotomy), Disease (Reflex Disease, Hiatal Hernias), End User (Hospitals) - Global Forecast to 2022
The global foregut surgery devices market is expected to reach USD 699.7 Million by 2023 from USD 485.1 Million in 2018, growing at a CAGR of 7.6% from 2018 to 2023. Rising incidence and prevalence of diseases, technological advancements, rising number of foregut surgical procedure some of the major driving factors driving the growth of the global foregut surgery devices market. However, the high cost of surgery hindering the growth of this market to a certain extent.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030
The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Incontinence and Ostomy Care Market by Procedure (Ileostomy, Urostomy, Colostomy), Disease (Cancer, Crohn's Disease, Diarrhea), Product (Adsorbent, Deodorizer, Ostomy Bag, Skin Barrier), Application (Protection, Cleansing) Global Forecasts to 2019
The global incontinence and ostomy care market is estimated to grow at a high rate from 2014 to 2019. The key drivers propelling the growth of global incontinence and ostomy care market include global rise in population of obese and geriatric individuals, development of innovative and personalized products offering greater patient comfort, rising awareness and acceptance related to ostomy care products, and increasing prevalence of target diseases.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology, Parasitology) - Global Forecast to 2022
The global poultry diagnostics market is projected to reach USD 495.3 Million by 2022 from USD 300.6 Million in 2017, growing at a CAGR of 10.5%. Significant increase in the avian diseases outbreak and rising incidence of zoonotic diseases, rising consumer focus on food safety along with the increasing animal health awareness, and increasing trade in terms of export within the poultry industry are the major drivers for the growth of the poultry diagnostics market.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022
The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe human microbiome market is expected to reach USD 1.31 billion by 2031, up from USD 0.29 billion in 2025, with a CAGR of 28.6% over the forecast period. Some of the leading players in the market include Ferring B.V. (Switzerland), OptiBiotix Health PLC (UK), BioGaia (Sweden), MaaT Pharma (France), Actial Farmaceutica srl (Italy), and nfant Bacterial Therapeutics AB. (Sweden), OxThera (Sweden), and Nexbiome (France), among others.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2030
The global periodontal disease treatment market, valued at US$2.44 billion in 2023, stood at US$2.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$3.63 billion by the end of the period. The growth of this market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for biopharmaceuticals, rapid growth of contract manufacturing companies to drive market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Formulas Market by Product (Polymeric, Elemental, Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) & Region - Global Forecast to 2027
The global enteral feeding formulas market growth is primed to transition from $5.2 billion in 2022 to $8.2 billion by 2027, showcasing a strong CAGR of 9.5%. Factors such as rising healthcare expenditure; a surge in the number of preterm births worldwide; growing aging population in need for enteral feeding; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition benefits; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
